SMARTICLESTM Technology
SMARTICLESTM Technology. Means Marina's NOV340 and other related lipid nanoparticle delivery technology and lipids owned or Controlled by Marina as of the Effective Date, or that comes to be owned or Controlled by Marina at any time during the New Technology Period, based on fully charge-reversible particles allowing delivery of active substance (siRNA, single-stranded oligonucleotides, etc.) inside a cell either by local or systemic administration.
All Definitions
Found in
Adhera Therapeutics, Inc. contract